Faster regulation procedures for German medtech aids ahead
This article was originally published in Clinica
Problems concerning the uptake of products into the German medical technical aids register (HMV) are a threat to technology advancement and must be eradicated. This was the view expressed by experts at a medical devices industry association (BVMed) special conference on "application procedures for the medtech aids register" last week in Bonn.
You may also be interested in...
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.
Trade group also compiled website with information and resources to help members "stay up to date and take any necessary steps to mitigate the risks associated with COVID-19." Its members also got a chance to describe potential supply chain disruptions in survey for USDA.